Department of Otolaryngology-Head and Neck Surgery, Eastern Virginia Medical School, Norfolk, Virginia 23507, USA.
Otol Neurotol. 2010 Dec;31(9):1473-9. doi: 10.1097/MAO.0b013e3181f7ab85.
The role for facial palsy in the Pittsburgh staging system for squamous cell carcinoma (SCC) of the external auditory canal (EAC) is unclear. The objective of this study was to conduct a systematic review of published studies to determine the impact of facial palsy on survival outcomes.
A search of MEDLINE, EMBASE, Cochrane Central Register of Clinical Trials, Cochrane, clinicaltrials.gov, and the National Guideline Clearinghouse databases was supplemented by hand searching.
Articles selected for final analysis had individual subject data on staging and/or facial nerve function, outcome, and follow-up period.
Data extracted included demographics, type and stage of cancer, survival, and facial nerve status.
Of 3,046 citations identified by a systematic literature search, 21 case series including 348 subjects with SCC of the EAC met criteria for analysis. The overall and disease-specific survival for subjects with facial palsy were significantly worse than subjects without facial palsy, regardless of stage (p = 0.006 and p = 0.002, respectively). The overall survival outcome for subjects with facial palsy was significantly worse than subjects with stage PITT-2000 T3-designated cancer (p = 0.027) and demonstrated no statistically significant difference from stage PITT-2000 T4-designated cancer (p = 0.897).
This pooled-data survival analysis for SCC of the EAC demonstrates that facial nerve involvement is associated with a poor outcome and that the survival outcomes for subjects with facial palsy more closely parallel the survival curves of advanced stage T4 disease. Disease with facial palsy should be classified as stage T4, in accordance with the PITT-2000 system.
面瘫在外耳道鳞癌(EAC)的匹兹堡分期系统中的作用尚不清楚。本研究的目的是对已发表的研究进行系统回顾,以确定面瘫对生存结果的影响。
对 MEDLINE、EMBASE、Cochrane 临床对照试验中心注册库、Cochrane、clinicaltrials.gov 和国家指南清除中心数据库进行了检索,并辅以手工检索。
入选的文章有关于分期和/或面神经功能、结局和随访期的个体患者数据。
提取的数据包括人口统计学、癌症类型和分期、生存和面神经状态。
通过系统文献搜索共确定了 3046 条引用,其中 21 项病例系列研究共纳入了 348 例 EAC 鳞癌患者,符合分析标准。无论分期如何,有面瘫的患者的总体生存率和疾病特异性生存率均明显低于无面瘫的患者(p = 0.006 和 p = 0.002)。有面瘫的患者的总体生存结局明显差于分期为 PITT-2000 T3 指定癌症的患者(p = 0.027),与分期为 PITT-2000 T4 指定癌症的患者无统计学差异(p = 0.897)。
本 EAC 鳞癌汇总数据生存分析表明,面神经受累与不良结局相关,有面瘫的患者的生存结局与晚期 T4 疾病的生存曲线更为接近。面瘫疾病应根据 PITT-2000 系统归类为 T4 期。